Less than a week ago,
), an agricultural products company, acquired a few assets of
Agradis Inc.; an agricultural solutions provider, from co
founders Synthetic Genomics and Plenus for an undisclosed price.
In addition, Monsanto also signed a multi-year research
collaboration agreement with Synthetic Genomics and also made an
equity investment in the latter.
The acquisition involves the purchase of the brand name
"Agradis" and a collection of the company's microbes, useful for
improving crop productivity. With the purchase of Agradis'
assets, Monsanto will be able to offer better products and
solutions to its customers, which can result in improved crop
health and productivity.
Agradis was co-founded by Synthetic Genomics Inc. (SGI) and a
Mexican company, Plenus S.A. de C.V. (Plenus) in the year 2011,
with a motive to provide farmers with improved agricultural
solutions. The chief focus of Agradis was on developing and
commercializing products to enhance crop production efficiency
through the use of new advances in genomics and plant breeding.
The founder companies, after the acquisition, will continue to
work on the remaining assets of Agradis under a new company,
The multi year research collaboration with Synthetic Genomics,
also included in the latest deal will involve developing some
biological products for Monsanto to enable improvement in
Also, in another press release, the company announced the
approval of a dividend payment of 37.5 cents per share. The
shareholders on record as on Apr 5, 2013, will receive the
dividend on Apr 26, 2013.
Monsanto currently holds a Zacks Rank #2 (Buy). Other stocks
worth a look in the industry are
Gruma S.A.B. de CV
), holding a Zacks Rank #1 (Strong Buy) and
) as well as
Deere & Company
); each holding a Zacks Rank #2 (Buy).
DEERE & CO (DE): Free Stock Analysis
GRUMA SA-ADR B (GMK): Free Stock Analysis
MONSANTO CO-NEW (MON): Free Stock Analysis
SYNGENTA AG-ADR (SYT): Free Stock Analysis
To read this article on Zacks.com click here.